Citation Impact
Citing Papers
Clinical guidelines on the management of hepatitis C
2001
Effects of short-term cortisol infusion on growth hormone-releasing hormone stimulation of growth hormone release in sheep
1995
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Acromegaly
2006 Standout
Epidemiology of viral hepatitis and HIV co-infection
2005
Hepatitis C virus: Epidemiology and transmission
1997
Hepatitis C: the clinical spectrum of the disease
1999
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Interferon as treatment for acute hepatitis C
1996
Use of polymerase chain reaction and antibody tests in the diagnosis of vertically transmitted hepatitis C virus infection
1997
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Hepatitis C Virus Infection
2001 Standout
Natural History of Perinatal Hepatitis C Virus Infection
1996
Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment
1992
Natural history of hepatitis C
1999
Association of hepatitis C virus envelope proteins with exosomes
2004 StandoutNobel
Treatment triumphs
2014 StandoutNatureNobel
Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C
2002
Meta-Analysis of Trials Comparing Minimally-Invasive and Open Liver Resections for Hepatocellular Carcinoma
2011
Endobronchial Ultrasound-Driven Biopsy in the Diagnosis of Peripheral Lung Lesions
2005
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Cushing's syndrome
2015 Standout
Cholinergic control of growth hormone (GH) responses to GH‐releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback
1993
Effect of the combined administration of galanin and clonidine on serum growth hormone levels in normal subjects and in patients under chronic glucocorticoid treatment
1994
Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery before the Implementation of Blood-Donor Screening
1999
The role of glucocorticoids in the regulation of growth hormone secretion Mechanisms and clinical significance
1992
Meta-markers for the differential diagnosis of lung cancer and lung disease
2016
Growth hormone treatment in aging: state of the art and perspectives
1997
Effect of Galanin on the Growth Hormone (GH) Response to Ghreleasing Hormone in Patients with Cushing's Disease
1993
Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children
1998
Inhibitory effects of galanin on growth hormone (GH) release in cultured GH-secreting adenoma cells: Comparative study with octreotide, GH-releasing hormone, and thyrotropin-releasing hormone
1997
Cell Mediated Immune Response to the Hepatitis C Virus
2000
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing
1995
Mother‐to‐infant transmission of hepatitis C virus: Rate of infection and assessment of viral load and IgM anti‐HCV as risk factors*
2002
Mother-to-infant transmission of hepatitis C virus
1999
Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region
1996
Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement.
1992
Perinatal Transmission of Hepatitis C Virus from Human Immunodeficiency Virus Type 1‐Infected Mothers
1998
Short term pirenzepine treatment is ineffective in suppressing 24-h growth hormone secretion in type 1 diabetes mellitus
1993
Hepatitis C virus (HCV) genotype analysis in apparently healthy anti‐ HCV‐positive Parisian blood donors
1996
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Glucocorticoid-induced Osteoporosis
2000
Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus
1997
Epidemiology of hepatitis C
1997 Standout
Global epidemiology of hepatitis C virus infection
2005 Standout
Protective Immune Response to Hepatitis C Virus in Chimpanzees Rechallenged Following Clearance of Primary Infection
2001 StandoutNobel
Hepatitis C and Pregnancy
2006
Risk of hepatitis C seroconversion after occupational exposures in health care workers*1
1995
Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats
1995
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender
1998
Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly
1993
Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients
1997
Maturation of the Regulation of Growth Hormone Secretion in Young Males with Hypogonadotropic Hypogonadism Pharmacologically Exposed to Progressive Increments in Serum Testosterone1
1997
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
2012 Standout
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Prevention of spread of hepatitis C
2002
Hepatitis C Virus: Epidemiology, Transmission and Prevention
1998
Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case-control study in Italy
1997
Effects of pyridostigmine on spontaneous and growth hormone‐releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation
1991
Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone.
1995
Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II diabetic patients
1994
Hepatitis C virus-specific T lymphocyte responses
1995 StandoutNobel
The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man
1991
Prospective study of mother‐to‐infant transmission of hepatitis C virus: a 10‐year survey (1990–2000)
2003
Transport of viruses through fetal membranes: An in vitro model of perinatal transmission
1998
Variability in the growth hormone response to growth hormone-releasing hormone alone or combined with pyridostigmine in type 1 diabetic patients
1993
Effect of glucocorticoids on the paradoxical growth hormone response to thyrotropin-releasing hormone in patients with acromegaly
1995
Global control of hepatitis C: where challenge meets opportunity
2013
Hyperprolactinemia and Prolactinomas
2008
Differential Regulation of Lipoprotein and Hepatitis C Virus Secretion by Rab1b
2017 StandoutNobel
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women
1995
Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women
2000
Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers
1998
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Effect of GHRP-6 and ghrh on gh secretion in rats following chronic glucocorticoid treatment
1995
Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load
2003
Pyridostigmine Blocks the Inhibitory Effect of Glucocorticoids on Growth Hormone-Releasing Hormone Stimulated Growth Hormone Secretion in Normal Man
1990
Ghrelin: Structure and Function
2005 Standout
Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency.
1994
Growth hormone neuroregulation in diabetes mellitus
1994
Mechanism of ribosome recruitment by hepatitis C IRES RNA
2001 StandoutNobel
Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis
1995
Hypothalamic control of growth hormone (GH) secretion in type i diabetic men: Effect of the combined administration of gh-releasing hormone and hexarelin, a novel GHRP-6 analog.
1996
Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency Virus
2000
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide
1995
Adrenocorticotropin- and Cortisol-Releasing Effect of Hexarelin, a Synthetic Growth Hormone-Releasing Peptide, in Normal Subjects and Patients with Cushing’s Syndrome1
1997
Hepatitis C and HIV-1 coinfection
2002
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein
2009 StandoutNobel
Interferon for acute hepatitis C
2001
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Hepatitis C in the HIV-Infected Person
2003
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
1995
Does the healthy hepatitis C virus carrier state really exist? an analysis using polymerase chain reaction
1995
Hepatitis C
1997
Detection of TT Virus DNA and GB Virus Type C/Hepatitis G Virus RNA in Serum and Breast Milk: Determination of Mother-to-Child Transmission
2000
Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines
2007 StandoutNobel
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection
2004 StandoutNobel
Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-Acting Antiviral Agents
2014 StandoutNobel
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Isolation of Multiple TT Virus Genotypes from Spleen Biopsy Tissue from a Hodgkin's Disease Patient: Genome Reorganization and Diversity in the Hypervariable Region
2004 StandoutNobel
Characterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell Binding
2006 StandoutNobel
Dominant Role of Host Selective Pressure in Driving Hepatitis C Virus Evolution in Perinatal Infection
2000
Neuroendocrine Control of Growth Hormone Secretion
1999
Works of G Pizzocolo being referenced
Comparative Effect of Clonidine and Growth Hormone (GH)-Releasing Hormone on GH Secretion in Adult Patients on Chronic Glucocorticoid Therapy
1992
Effects of Short-Term Glucocorticoid Deprivation on Growth Hormone (GH) Response to GH-Releasing Hormone in Man
1989
EFFECTS OF INTRANASAL CALCITONIN ADMINISTRATION ON PITUITARY GH RESPONSE TO hGHRH (1–29)NH2 IN NORMAL ADULT SUBJECTS
1989
Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in Type I diabetic patients
1991
Acute Effects of Hydrocortisone on Circulating Growth Hormone Levels in Patients with Acromegaly
1992
Impaired Growth Hormone (GH) Response to Pyridostigmine in Type 1 Diabetic Patients with Exaggerated GH-Releasing Hormone-Stimulated GH Secretion*
1990
Clinical Significance of a Multiple Biomarker Assay in Patients with Lung Cancer
1990
Pyridostigmine Enhances Even if it Does Not Normalize the Growth Hormone Responses to Growth Hormone-Releasing Hormone in Patients with Cushing’s Disease
1991
HCV-RNA detection in ultrasound-guided fine needle biopsies of liver nodules and surrounding tissue
1994
EFFECTS OF CALCITONIN ON GH RESPONSE TO PYRIDOSTIGMINE IN COMBINATION WITH hGHRH (1–29) NH2 IN NORMAL ADULT SUBJECTS
1990
Central Alpha-2 Adrenergic Function in Patients with Essential Hypertension
1990
Mother-to-infant transmission of hepatitis C virus
1995
Hepatitis C virus viremia following clinical resolution of acute hepatitis C
1994
Effects of sex and age on the growth hormone response to galanin in healthy human subjects.
1993
Clinical significance of serum hepatitis C virus (HCV) RNA as marker of HCV infection
1994
Galanin decreases circulating growth hormone levels in acromegaly.
1992
Physiological role of galanin in the regulation of anterior pituitary function in humans
1994
Acute Effect of Propranolol on the Growth Hormone (GH) Response to GH-Releasing Hormone in Patients with Hyperthyroidism
1991
Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy.
1992